82 related articles for article (PubMed ID: 22264836)
1. [Monitoring of intraperitoneal administration of vancomycin in patients on continuous ambulatory peritoneal dialysis].
Montañés-Pauls B; Alós Almiñana M; Casabó Alós VG; García Pérez H
Farm Hosp; 2012; 36(5):328-35. PubMed ID: 22264836
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
3. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
5. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
9. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
[TBL] [Abstract][Full Text] [Related]
10. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report.
Company-Albir MJ; García-Robles A; Torres-Martinez E; Marqués-Miñana MR; Vento-Torres M; Poveda JL
J Clin Pharm Ther; 2019 Aug; 44(4):647-649. PubMed ID: 31032996
[TBL] [Abstract][Full Text] [Related]
12. [Peritonitis among patients treated with continuous ambulatory peritoneal dialysis].
Bistrup C; Siboni AH; Pedersen RS
Ugeskr Laeger; 1995 Jul; 157(28):4023-6. PubMed ID: 7645077
[TBL] [Abstract][Full Text] [Related]
13. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
[TBL] [Abstract][Full Text] [Related]
14. [Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study].
De Groc F; Rottembourg J; Jacq D; Jarlier V; N'Guyen J; Legrain M
Nephrologie; 1983; 4(1):24-7. PubMed ID: 6843764
[TBL] [Abstract][Full Text] [Related]
15. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
16. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gucek A; Bren AF; Hergouth V; Lindic J
Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
Mounier M; Benevent D; Denis F
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
